Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases

Por Kraehn, G M, Utikal, J, Udart, M, Greulich, K M, Bezold, G, Kaskel, P, Leiter, U, Peter, R U
Publicado em 2001

Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancer

Por Schneider, T, Sevko, A, Heussel, C P, Umansky, L, Beckhove, P, Dienemann, H, Safi, S, Utikal, J, Hoffmann, H, Umansky, V
Publicado no Clin Exp Immunol (2015)

Detection of ABCB5 tumour antigen‐specific CD8(+) T cells in melanoma patients and implications for immunotherapy

Por Borchers, S., Maβlo, C., Müller, C. A., Tahedl, A., Volkind, J., Nowak, Y., Umansky, V., Esterlechner, J., Frank, M. H., Ganss, C., Kluth, M. A., Utikal, J.
Publicado no Clin Exp Immunol (2017)

Differential influence of vemurafenib and dabrafenib on patients’ lymphocytes despite similar clinical efficacy in melanoma

Por Schilling, B., Sondermann, W., Zhao, F., Griewank, K. G., Livingstone, E., Sucker, A., Zelba, H., Weide, B., Trefzer, U., Wilhelm, T., Loquai, C., Berking, C., Hassel, J., Kähler, K. C., Utikal, J., Al Ghazal, P., Gutzmer, R., Goldinger, S. M., Zimmer, L., Paschen, A., Hillen, U., Schadendorf, D.
Publicado no Ann Oncol (2014)

Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study

Por Gutzmer, R, Rivoltini, L, Levchenko, E, Testori, A, Utikal, J, Ascierto, P A, Demidov, L, Grob, J J, Ridolfi, R, Schadendorf, D, Queirolo, P, Santoro, A, Loquai, C, Dreno, B, Hauschild, A, Schultz, E, Lesimple, T P, Vanhoutte, N, Salaun, B, Gillet, M, Jarnjak, S, De Sousa Alves, P M, Louahed, J, Brichard, V G, Lehmann, F F
Publicado no ESMO Open (2016)

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

Por Long, G. V., Flaherty, K. T., Stroyakovskiy, D., Gogas, H., Levchenko, E., de Braud, F., Larkin, J., Garbe, C., Jouary, T., Hauschild, A., Chiarion-Sileni, V., Lebbe, C., Mandalà, M., Millward, M., Arance, A., Bondarenko, I., Haanen, J. B. A. G., Hansson, J., Utikal, J., Ferraresi, V., Mohr, P., Probachai, V., Schadendorf, D., Nathan, P., Robert, C., Ribas, A., Davies, M. A., Lane, S. R., Legos, J. J., Mookerjee, B., Grob, J.-J.
Publicado no Ann Oncol (2017)